Pregnancy and the Kidney

被引:101
作者
Maynard, Sharon E. [1 ]
Thadhani, Ravi [2 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Med, Div Renal Dis & Hypertens,Med Fac Associates, Washington, DC 20037 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Renal Unit, Boston, MA USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 20卷 / 01期
基金
美国国家卫生研究院;
关键词
CIRCULATING ANGIOGENIC FACTORS; PLACENTAL GROWTH-FACTOR; GLOMERULAR-FILTRATION-RATE; TYROSINE KINASE-1; SOLUBLE ENDOGLIN; MATERNAL PLASMA; SIGNIFICANT PROTEINURIA; ANTIANGIOGENIC FACTORS; PREVENT PREECLAMPSIA; SERUM-LEVELS;
D O I
10.1681/ASN.2008050493
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Nephrologists are frequently called on to diagnose and treat renal disorders in pregnant women. In this review, we update recent literature pertinent to pregnancy and renal disease. We initially begin by describing the application of common clinical estimators of GFR and proteinuria in pregnancy and then summarize recent studies regarding pregnancy in women with chronic kidney disease and the latest information on the use of common renal medications in pregnancy. In the final section, we describe advances in our understanding of the pathophysiology of preeclampsia and the potential clinical implications of these discoveries for screening, prevention, and treatment of preeclampsia.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 106 条
  • [1] ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67
  • [2] Low urinary placental growth factor is a marker of pre-eclampsia
    Aggarwal, PK
    Jain, V
    Sakhuja, V
    Karumanchi, SA
    Jha, V
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (03) : 621 - 624
  • [3] Estimation of glomerular filtration rate in preeclamptic patients
    Alper, Arnold B.
    Yi, Yeonjoo
    Webber, Larry S.
    Pridjian, Gabriella
    Mumuney, Abimbola Aina
    Saade, George
    Morgan, Jamie
    Nuwayhid, Bahij
    Belfort, Michael
    Puschett, Jules
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2007, 24 (10) : 569 - 574
  • [4] Angiotensin II receptor antagonist treatment during pregnancy
    Alwan, S
    Polifka, JE
    Friedman, JM
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (02) : 123 - 130
  • [5] [Anonymous], 1993, Lancet, V341, P396
  • [6] Armenti Vincent T, 2004, Clin Transpl, P103
  • [7] Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
    Askie, Lisa M.
    Duley, Lelia
    Henderson-Smart, David J.
    Stewart, Lesley A.
    [J]. LANCET, 2007, 369 (9575) : 1791 - 1798
  • [8] Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction
    Barber, A
    Robson, SC
    Myatt, L
    Bulmer, JN
    Lyall, F
    [J]. FASEB JOURNAL, 2001, 15 (07) : 1158 - 1168
  • [9] Circulating angiogenic proteins in trisomy 13
    Bdolah, Y
    Palomaki, GE
    Yaron, Y
    Bdolah-Abram, T
    Goldman, M
    Levine, RJ
    Sachs, BP
    Haddow, JE
    Karumanchi, SA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 194 (01) : 239 - 245
  • [10] BEROYZ G, 1994, LANCET, V343, P619